If you don't have exactly 7 cards in your hand, this attack does nothing.
Ascended Heroes was released in 2026. Ascended Heroes is grouped under the Mega Evolution era.
The checklist contains 295 cards, placing it in a very large expansion range. As of this year, it is one of the newest tracked releases.
In the Ascended Heroes checklist, Medicham occupies position #104 as a Common card.
Medicham appears in Ascended Heroes, released in 2026. Its card type is Pokémon., The rarity label is Common., Printed HP is 120., and Energy typing is Fighting.
This gives collectors a clear identity footprint for the print. Medicham evolves from Meditite.
Notable move text references "Seventh Kick". The card has a weakness to Psychic.
Retreat cost is 1 energy. Common-tier prints are typically the most accessible entries for set completion.
Medicham (Ascended Heroes) is presently valued at about $0.17 in raw condition. Its 7-day trend is negative at 5.6%.
Current value trails the 30-day mean ($0.33) by 48.0%. In the past 90 days, observed prices ranged from $0.17 to $0.70 (312% spread), a high-volatility profile.
This version is categorized as Common.
A wider Medicham checklist helps contextualize this specific Medicham print. This comparison sample includes 6 alternatives across 5 sets.
Comparable prices currently cover $0.07-$10.39, a 14743% band. Against the sample mean of $1.97, this card is -91%.
Notable alternatives include Medicham #241 (Ascended Heroes) at $10.39, Medicham #80 (Primal Clash) at $0.58, Medicham #81 (Primal Clash) at $0.50, and Medicham #98 (Rebel Clash) at $0.11.
Collector-focused market read: Week-over-week movement is negative (5.6%); this leaves value 76% under the 90-day peak. Observed 90-day bounds of $0.17 and $0.70 create a 312% band, matching a high-volatility profile.
Current value is 48.0% below its 30-day reference ($0.33). No consistent graded benchmark is available in this snapshot, so condition-adjusted pricing should be reviewed with active listings.
